Episode Details

Back to Episodes
Episode 047: Myeloma Series, Pt. 8 – Myeloma Maintenance Therapy

Episode 047: Myeloma Series, Pt. 8 – Myeloma Maintenance Therapy

Episode 47 Published 3 years, 8 months ago
Description

We continue our myeloma series, transitioning our discussion from autologous stem cell transplant to maintenance therapy for myeloma.

Content:

- Why do we use revlimid (lenalidomide) maintenance?

- What about in high risk patients?

- What is the role of MRD testing?

- What about daratumumab in the maintenance setting?

This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co.

Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us